Cargando…

Peanut oral immunotherapy may improve health‐related quality of life among severe peanut allergic adolescents

Detalles Bibliográficos
Autores principales:	Ödling, Maria, Sundqvist, Ann‐Charlotte, Brandström, Josef, Nopp, Anna, Andersson, Niklas, Nilsson, Caroline, Kull, Inger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899491/ https://www.ncbi.nlm.nih.gov/pubmed/36825514 http://dx.doi.org/10.1002/clt2.12225

Ejemplares similares

A pilot study towards the immunological effects of omalizumab treatment used to facilitate oral immunotherapy in peanut‐allergic adolescents
por: van der Heiden, Marieke, et al.
Publicado: (2020)

Oral Peanut Challenge Identifies an Allergy but the Peanut Allergen Threshold Sensitivity Is Not Reproducible
por: Glaumann, Susanne, et al.
Publicado: (2013)

Home-Based Peanut Oral Immunotherapy for Low-Risk Peanut-Allergic Preschoolers During the COVID-19 Pandemic and Beyond
por: Chua, Gilbert T., et al.
Publicado: (2021)

T cell specific and non specific tolerance mechanisms in peanut oil immunotherapy in peanut allergic subjects
por: Singh, Amit, et al.
Publicado: (2011)

Peanut immunotherapy
por: Anagnostou, Katherine, et al.
Publicado: (2014)

Peanut thresholds in peanut‐allergic children are related to dietary composition
por: Luiten, Daisy, et al.
Publicado: (2023)

Peanut Immunotherapy: Stepping Towards Desensitization for Peanut Allergy
por: Hsu, Joyce
Publicado: (2020)

Oral immunotherapy for peanut allergy: The pro argument
por: Chinthrajah, R. Sharon, et al.
Publicado: (2020)

Peanut Oral Immunotherapy: a Current Perspective
por: Patrawala, Meera, et al.
Publicado: (2020)

Oral immunotherapy for peanut allergy: The con argument
por: Fiocchi, Alessandro, et al.
Publicado: (2020)

Peanut allergy: Beyond the oral immunotherapy plateau
por: Bruton, Kelly, et al.
Publicado: (2021)

Interpreting success or failure of peanut oral immunotherapy
por: Cao, Shijie, et al.
Publicado: (2022)

Transitioning peanut oral immunotherapy to clinical practice
por: Lazizi, S., et al.
Publicado: (2022)

Transitioning from epicutaneous to oral peanut immunotherapy
por: Wong, Lauren, et al.
Publicado: (2023)

Peanut allergy may be overdiagnosed in younger siblings of those with confirmed peanut allergy
por: Lavine, Elana, et al.
Publicado: (2014)

Response to major peanut and peach allergens in a population of children allergic to peanut
por: Blanca, Miguel
Publicado: (2014)

Response to major peanut and peach allergens in a population of children allergic to peanut
por: Garcia-Blanca, Alexandra, et al.
Publicado: (2015)

Long-term safety and immunologic outcomes of daily oral immunotherapy for peanut allergy
por: Bird, J. Andrew, et al.
Publicado: (2023)

Peanut oral immunotherapy: current trends in clinical trials
por: Reinwald, Simone, et al.
Publicado: (2022)

Peanut oral immunotherapy in adolescents: study protocol for a randomized controlled trial
por: Michaud, Elodie, et al.
Publicado: (2015)

Should Younger Siblings of Peanut-Allergic Children Be Assessed by an Allergist before Being Fed Peanut?
por: Liem, Joel J, et al.
Publicado: (2008)

Peanut components measured by ISAC: comparison with ImmunoCap and clinical relevance in peanut allergic children
por: Brand, H. K., et al.
Publicado: (2021)

Development of sensitization to peanut and storage proteins and relation to markers of airway and systemic inflammation: A 24‐year follow‐up
por: Tedner, Sandra G., et al.
Publicado: (2022)

Insights into Microbiome and Metabolic Signatures of Children Undergoing Peanut Oral Immunotherapy
por: Blackman, Andrea C., et al.
Publicado: (2022)

Biomarkers of severity and threshold of allergic reactions during oral peanut challenges
por: Santos, Alexandra F., et al.
Publicado: (2020)

Mouse strain differences in response to oral immunotherapy for peanut allergy
por: Wagenaar, Laura, et al.
Publicado: (2019)

Risk factors associated with safety of preschool peanut oral immunotherapy
por: Karunakaran, Duva, et al.
Publicado: (2023)

Optimal period for achieving sustained unresponsiveness in peanut oral immunotherapy
por: Yamashita, Kosei, et al.
Publicado: (2023)

Health-related quality of life decreases in young people with asthma during the transition from adolescence to young adulthood: a birth cohort study
por: Ödling, Maria, et al.
Publicado: (2023)

Vitamin D levels in peanut allergic children
por: Fowlie, Adam, et al.
Publicado: (2011)

Induction of Allergic Responses to Peanut Allergen in Sheep
por: Van Gramberg, Jenna L., et al.
Publicado: (2012)

Relevance of sensitization to legumes in peanut‐allergic children
por: Muller, Timé, et al.
Publicado: (2022)

Risk Factors for Anaphylaxis in Children Allergic to Peanuts
por: Petek, Tadej, et al.
Publicado: (2023)

Adjuvanted Immunotherapy Approaches for Peanut Allergy
por: Johnson-Weaver, Brandi T., et al.
Publicado: (2018)

A novel peanut allergoid is safe and effective in immunotherapy in a peanut allergy mouse model
por: Smit, J, et al.
Publicado: (2013)

Peanut Sensitization Profiles in Italian Children and Adolescents with Specific IgE to Peanuts
por: Calamelli, Elisabetta, et al.
Publicado: (2013)

The relevance of oral food challenge in a patient allergic to peanut and tree nuts
por: Limão, Rita, et al.
Publicado: (2023)

Effect of ketotifen premedication on adverse reactions during peanut oral immunotherapy
por: Jagdis, Amanda, et al.
Publicado: (2014)

Treatment of allergic reactions to peanut in recent versus initial reaction
por: Ben-Shoshan, Moshe, et al.
Publicado: (2010)

Basophil allergen threshold sensitivity, and peanut allergen components in relation to DBPCFC in children with suspected peanut allergy
por: Nilsson, Caroline, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_l4sauuo066nfita8fc3gq4oc9i